Publications by authors named "M Wato"
Article Synopsis
- * Laboratory tests indicated an infection, and imaging showed bowel issues along with fluid accumulation in the abdomen.
- * After starting treatment with prednisolone, her symptoms improved significantly, highlighting the need for awareness of potential severe colitis as a rare reaction to COVID-19 vaccines.
Article Synopsis
- The study evaluated the risk factors and drug differences associated with post-endoscopic submucosal dissection (ESD) bleeding in patients using antithrombotic drugs, specifically direct oral anticoagulants (DOACs).
- Out of 278 patients, those on DOACs experienced a 19.6% incidence of post-ESD bleeding, with risk factors including larger resection size and presence of neutrophil infiltration.
- The findings suggest that DOACs elevate bleeding risk, particularly noting lower bleeding rates with the drug dabigatran compared to others like apixaban, edoxaban, and rivaroxaban.
[Cystic duct carcinoma in a patient with a history of cholecystectomy: a case report].
Nihon Shokakibyo Gakkai Zasshi
April 2024
An 83-year-old Japanese man who underwent cholecystectomy for cholecystolithiasis 17 years ago visited our hospital owing to epigastric pain. He was initially diagnosed with choledocholithiasis and acute cholangitis following white blood cell, C-reactive protein, total bilirubin, alkaline phosphatase, and γ-glutamyltranspeptidase level elevations along with common bile duct stones on computed tomography (CT). Moreover, CT, magnetic resonance imaging, endoscopic retrograde cholangiography (ERC), and endoscopic ultrasonography (EUS) also revealed a 2-cm-diameter mass arising from the remnant cystic duct.
View Article and Find Full Text PDFIntroduction: Non-curative endoscopic resection of T1 colorectal cancer (CRC) carries a substantial risk of recurrence. However, previous studies have reported a significant proportion of cases in which the deep margin of endoscopic resection was positive for cancer due to the technical difficulties of colorectal endoscopic submucosal dissection (ESD). With the advancement of endoscopic technology and techniques resulting in the reduction of positive resection margins, it is important to reassess the long-term prognosis and major risk factors for recurrence in cases of negative deep margins.
View Article and Find Full Text PDFBackground And Aims: Cholecystitis can occur after self-expandable metallic stent (SEMS) placement for malignant biliary obstruction (MBO), but the best treatment option for cholecystitis has not been determined. Here, we aimed to identify the risk factors of cholecystitis after SEMS placement and determine the best treatment option.
Methods: Incidence, treatments, and predictive factors of cholecystitis were retrospectively evaluated in 1084 patients with distal MBO (DMBO) and 353 patients with hilar MBO (HMBO) who underwent SEMS placement at 12 institutions from January 2012 to March 2021.